• Empowering Community Oncologists in the New Era of Cancer Management: The Immuno-Oncology Regional Meeting Series - Register Now
  • Earn CME Now
  • View New CE Activity Now
  • Register Now
  • New Options, New Hope: Recent Chemotherapeutic Advances in Metastatic Pancreatic Cancer
  • ASH 2013 Meeting Highlights in CML
  • Managing Breakthrough Pain Across the Provider Continuum
  • ASCO 2013 Meeting Highlights in Lung Cancer
  • Managing Myeloma ASCO 2013 Meeting Highlights
  • ASCO 2013 Meeting Highlights in Hematologic Malignancies

What's New

CE Education
Evolving Treatment Paradigms in Chronic Lymphocytic Leukemia: Challenging Cases and Expert Strategies
Susan M. O’Brien, MD – Chair; John C. Byrd, MD; Nicole Lamanna, MD
CE Education
Aligning Current Practice in Febrile Neutropenia with Guideline-based Care
James O. Armitage, MD – Moderator; R. Donald Harvey, PharmD, FCCP, BCOP; Gary H. Lyman, MD, MPH, FASCO
FAQ Library
What are the recommended management strategies for patients with low-risk febrile neutropenia?
Christopher R. Flowers, MD

What is the incidence of febrile neutropenia (FN) in patients receiving chemotherapy?
R. Donald Harvey, III, PharmD, FCCP, BCOP

How do you define chemotherapy-related febrile neutropenia?
R. Donald Harvey, III, PharmD, FCCP, BCOP

What are the risk factors for the development of febrile neutropenia (FN) in patients receiving chemotherapy?
R. Donald Harvey, III, PharmD, FCCP, BCOP